Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02702687
Other study ID # 2014-3257
Secondary ID 1R01HL128260-01
Status Completed
Phase N/A
First received
Last updated
Start date May 2016
Est. completion date July 28, 2022

Study information

Verified date February 2023
Source Albert Einstein College of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized controlled trial will include Latino and Black adolescents with asthma ages 10-17 years old and their caregivers. Participants will be recruited from clinics in the Bronx, New York. The primary aims are to examine the efficacy of peak expiratory flow (PEF) prediction with feedback versus control feedback on 1) under-perception of asthma symptoms 2) controller medication adherence and 3) asthma control and emergency health care use. These aims will be examined across a 1-year follow-up. An exploratory aim examines the hypothesized pathway that the PEF intervention reduces under-perception of symptoms, shifts illness representations toward the professional model and increases adolescents' and parents' asthma management self-efficacy, resulting in greater medication adherence and improved asthma control.


Description:

Under-perception of asthma symptoms in children is a major risk factor for emergency department visits, hospitalizations, and near-fatal/fatal asthma attacks. Puerto Rican and Black children have greater asthma morbidity and mortality rates than all other racial/ethnic groups. Interventions targeting asthma symptom perception and medication adherence may help close this asthma health disparities gap. The baseline visit for all families consists of standardized asthma education followed by 3 weeks of PEF prediction without feedback using a programmable, electronic spirometer. Participants then will be randomized to intervention group or control feedback group and receive a brief feedback session. For the next 6 weeks, all adolescents will predict their PEF, which will be locked in before blowing into the device. Families will return at mid-intervention and post-intervention to receive feedback sessions. All adolescents will play an interactive asthma educational game to reinforce the baseline asthma education. At the post-intervention visit, the spirometer will be reprogrammed for the next 4 weeks. These symptom perception data will be downloaded at 1-month post-intervention. Controller medication adherence will be monitored by electronic devices. Post-intervention sessions will take place at 3, 6, 9, and 12 months to collect adherence data and conduct spirometry. Physicians will be blinded to group assignment and rate asthma severity using national guidelines. A 12-month retrospective medical record abstraction will compare emergency health care use for asthma between groups.


Recruitment information / eligibility

Status Completed
Enrollment 363
Est. completion date July 28, 2022
Est. primary completion date July 28, 2022
Accepts healthy volunteers No
Gender All
Age group 10 Years to 17 Years
Eligibility Inclusion Criteria: - 10-17 years of age - Diagnosis of asthma (in medical record) - Report of breathing problems within the past 12 months - Prescribed a controller medication for asthma - At least one parent self-identifies as Latino or Black - The participating parent has primary or at least equal responsibility for the adolescent Exclusion Criteria: - Cognitive learning disability (parent report) - No prescription for asthma controller medication - Inability to perform acceptable PEF blows - Race/ethnicity other than Latino or Black - Other significant pulmonary conditions (cystic fibrosis)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
PEF Feedback
Intervention group will receive PEF feedback and verbal feedback sessions across 3 feedback visits and asthma education.
Control Feedback
Control feedback group will receive feedback consisting of standardized messages and have 3 control feedback visits and asthma education.

Locations

Country Name City State
United States Jacobi Medical Center Bronx New York
United States Montefiore Medical Center Bronx New York

Sponsors (2)

Lead Sponsor Collaborator
Albert Einstein College of Medicine National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Asthma Symptom Perception with Asthma Monitor (AM2) as percentage of guesses in the Under-Perception zone The percentage of times a child under-perceives the severity of asthma symptoms Change from Pre-intervention to 12-month-follow-up (15 months)
Secondary Asthma Illness Representation Scale (AIRS) 37-item scale measuring risk factors for the underutilization of controller medications Change from Pre-intervention to 12-month-follow-up (15 months)
Secondary Asthma Management Self-Efficacy (ASE) scale: Parent and child versions 13-item scale measures parent's confidence in their ability to help manage child's asthma Change from Pre-intervention to 12-month-follow-up (15 months)
Secondary Pediatric Asthma Quality of Life Questionnaire (PAQLQ) 23-item self report questionnaire assessing child's overall functioning in relation to asthma Change from Pre-intervention to 12-month-follow-up (15 months)
Secondary Medication Adherence - percentage of total doses taken per day/prescribed per day Self report of daily medication use, in relation to the prescribed use Change from Pre-intervention to 12-month-follow-up (15 months)
Secondary Health Care Use - Electronic Medical Record (EMR) review of asthma-related Emergency Department visits and hospitalizations Quantity of asthma-related emergency visits throughout the duration of the study Change from Pre-intervention to 12-month-follow-up (15 months)
Secondary Asthma Control Test (C-ACT) Self-report questionnaire for adolescents and parents Change from Pre-intervention to 12-month-follow-up (15 months)
See also
  Status Clinical Trial Phase
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device